生命科学资讯

CDER head Richard Pazdur set to retire shortly after appointment

Imvax takes brain cancer cell therapy to FDA, betting survival hit will overshadow primary miss

Tiziana to spin out IL-6 drug into new company, citing Big Pharma's interest in modality

Novocure promotes new CEO, replacing current chief after less than a year

Roche's point-of-care whooping cough test greenlighted in US, Europe as cases surge

FDA adopts agentic AI in latest push to infuse artificial intelligence into agency

Regeneron makes $150M bet on Tessera's rare disease gene writing prospect

European Union teams up with Angelini to funnel €150M to European health startups

Belite brings FDA filing into view with phase 3 Stargardt disease victory

GE HealthCare, Philips, Siemens spotlight AI-forward imaging at RSNA 2025

Researchers find chronic stress you can see using a CT scan

Akebia to pay $12M to Q32 Bio for centerpiece of rare kidney disease pipeline

Protego plans pivotal trial for AL amyloidosis prospect with $130M series B

Meeting patients where they are: tailored support to drive recruitment and retention

Hologic mammography studies show promise of AI in breast cancer detection

Vaccine-focused Valneva consolidates R&D footprint by shuttering site, eliminating 30 roles

ARPA-H launches program to fund autonomous stroke-treating robots

FDA delays decision on Ascendis' dwarfism prospect by 3 months

Ceribell scores FDA nod for detecting seizures in preterm newborns

AI may be the key to reigniting VC interest in biotech: PitchBook